Clinical Trial Detail

NCT ID NCT02023905
Title Everolimus With and Without Temozolomide in Adult Low Grade Glioma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors University of California, San Francisco
Indications

malignant glioma

Therapies

Temozolomide

Everolimus

Age Groups: adult

No variant requirements are available.